Baicalein improves the symptoms of polycystic ovary syndrome by mitigating oxidative stress and ferroptosis in the ovary and gravid placenta

Phytomedicine. 2024 Jun:128:155423. doi: 10.1016/j.phymed.2024.155423. Epub 2024 Feb 16.

Abstract

Background: Polycystic ovary syndrome is a metabolic and hormonal disorder that is closely linked to oxidative stress. Within individuals diagnosed with PCOS, changes occur in the ovaries, resulting in an excessive buildup of iron and peroxidation of lipids, both of which may be associated with the occurrence of ferroptosis. Baicalein, a flavonoid found in the roots of Scutellaria baicalensis and widely known as Chinese skullcap, is known for its anti-inflammatory and anti-ferroptotic properties, which protect against various diseases. Nevertheless, there has been no investigation into the impact of baicalein on polycystic ovary syndrome.

Purpose: This study aimed to correlate ferroptosis with polycystic ovary syndrome and to assess the effects of baicalein on ovarian dysfunction and placental development in pregnant patients.

Study design and methods: Polycystic ovary syndrome was induced in a rat model through the administration of dehydroepiandrosterone, and these rats were treated with baicalein. Oxidative stress and inflammation levels were assessed in serum and ovaries, and tissue samples were collected for histological and protein analyses. Furthermore, different groups of female rats were mated with male rats to observe pregnancy outcomes and tissue samples were obtained for histological, protein, and RNA sequencing. Then, RNA sequencing of the placenta was performed to determine the key genes involved in ferroptosis negative regulation (FNR) signatures.

Results: Baicalein was shown to reduce ovarian oxidative stress and pathology. Baicalein also ameliorated polycystic ovary syndrome by decreasing lipid peroxidation and chronic inflammation and modulating mitochondrial functions and ferroptosis in the ovaries. Specifically, glutathione peroxidase and ferritin heavy chain 1 were considerably downregulated in polycystic ovary syndrome gravid rats compared to their expression in the control group, and most of these differences were reversed after baicalein intervention.

Conclusions: Our findings, initially, indicated that baicalein could potentially enhance the prognosis of individuals suffering from polycystic ovary syndrome by reducing oxidative stress and ferroptosis, thus potentially influencing the formulation of a therapeutic approach to address this condition.

Keywords: Baicalein; Ferroptosis; Gravid placenta; Oxidative stress; Polycystic ovary syndrome.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Female
  • Ferroptosis* / drug effects
  • Flavanones* / pharmacology
  • Lipid Peroxidation / drug effects
  • Male
  • Ovary* / drug effects
  • Oxidative Stress* / drug effects
  • Placenta* / drug effects
  • Placenta* / metabolism
  • Polycystic Ovary Syndrome* / drug therapy
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Scutellaria baicalensis / chemistry

Substances

  • Flavanones
  • baicalein